CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...
Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback